Inogen (INGN) Shareholder's Equity (QoQ) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Inogen | 165.85 Mn | 71.44 Mn | 37.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.85% |
| Dec 31, 2025 | -2.51% |
| Sep 30, 2025 | -1.16% |
| Jun 30, 2025 | 0.78% |
| Mar 31, 2025 | 13.86% |
| Dec 31, 2024 | -6.23% |
| Sep 30, 2024 | -1.17% |
| Jun 30, 2024 | -2.24% |
| Mar 31, 2024 | -6.31% |
| Dec 31, 2023 | -11.19% |
| Sep 30, 2023 | -16.07% |
| Jun 30, 2023 | -2.32% |
| Mar 31, 2023 | -5.42% |
| Dec 31, 2022 | -15.23% |
| Sep 30, 2022 | -1.60% |
| Jun 30, 2022 | -0.49% |
| Mar 31, 2022 | -3.23% |
| Dec 31, 2021 | -5.29% |
| Sep 30, 2021 | 5.39% |
| Jun 30, 2021 | 4.11% |
| Mar 31, 2021 | 1.91% |
| Dec 31, 2020 | -0.82% |
| Sep 30, 2020 | 0.39% |
| Jun 30, 2020 | 1.10% |
| Mar 31, 2020 | 0.78% |
| Dec 31, 2019 | 0.43% |
| Sep 30, 2019 | 2.80% |
| Jun 30, 2019 | 3.70% |
| Mar 31, 2019 | 3.69% |
| Dec 31, 2018 | 6.58% |
| Sep 30, 2018 | 9.13% |
| Jun 30, 2018 | 8.35% |
| Mar 31, 2018 | 8.50% |
| Dec 31, 2017 | 2.60% |
| Sep 30, 2017 | 6.50% |
| Jun 30, 2017 | 7.78% |
| Mar 31, 2017 | 5.87% |
| Dec 31, 2016 | 5.49% |
| Sep 30, 2016 | 6.39% |
| Jun 30, 2016 | 7.75% |
| Mar 31, 2016 | 12.35% |
| Dec 31, 2015 | 3.15% |
| Sep 30, 2015 | 1.57% |
| Jun 30, 2015 | 4.37% |
| Mar 31, 2015 | 3.74% |
| Dec 31, 2014 | 3.73% |
| Sep 30, 2014 | 2.79% |
| Jun 30, 2014 | 2.70% |
| Mar 31, 2014 | 273.00% |
| Mar 31, 2013 | -1.20% |